Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced a significant share repurchase program, committing up to DKK 20 billion over 12 months starting February 2024, with DKK 2.2 billion allocated for purchases between May and August 2024. As part of this strategy, the company has recently bought back shares worth DKK 8.25 billion at an average price of DKK 866.73 each. This aggressive buyback reflects Novo Nordisk’s ongoing commitment to shareholder value and caps a period of active market engagement.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
